Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein

被引:230
作者
Zwerschke, W
Mazurek, S
Massimi, P
Banks, L
Eigenbrodt, E
Jansen-Dürr, P
机构
[1] Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany
[2] ScheBo Tech GmbH, D-35435 Wettenberg, Germany
[3] Univ Giessen, Fachbereich Vet Med, Inst Biochem & Endokrinol, D-35392 Giessen, Germany
[4] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy
关键词
glycolysis; cell transformation; cancer; virus;
D O I
10.1073/pnas.96.4.1291
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We report here that the E7 oncoprotein encoded by the oncogenic human papillomavirus (HPV) type 16 binds to the glycolytic enzyme type M-2 pyruvate kinase (M2-PK). M2-PK occurs in a tetrameric form with a high affinity to its substrate phosphoenolpyruvate and a dimeric form with a low affinity to phosphoenolpyruvate, and the transition between both conformations regulates the glycolytic flux in tumor cells. The glycolytic intermediate fructose 1,6-bisphosphate induces the reassociation of the dimeric to the tetrameric form of M2-PK. The expression of E7 in an experimental cell line shifts the equilibrium to the dimeric state despite a significant increase in the fructose 1,6-bisphosphate levels. Investigations of HPV-16 E7 mutants and the nononcogenic HPV-11 subtype suggest that the interaction of HPV-16 E7 with M2-PK may be linked to the transforming potential of the viral oncoprotein.
引用
收藏
页码:1291 / 1296
页数:6
相关论文
共 45 条
[41]   PHOSPHORYLATION OF PYRUVATE-KINASE AND GLYCOLYTIC METABOLISM IN 3 HUMAN GLIOMA CELL-LINES [J].
WEERNINK, PAO ;
RIJKSEN, G ;
STAAL, GEJ .
TUMOR BIOLOGY, 1991, 12 (06) :339-352
[42]  
WICE BM, 1985, J BIOL CHEM, V260, P139
[43]   SEQUENTIAL ACTIVATION OF CYCLIN-E AND CYCLIN-A GENE-EXPRESSION BY HUMAN PAPILLOMAVIRUS TYPE-16 E7 THROUGH SEQUENCES NECESSARY FOR TRANSFORMATION [J].
ZERFASS, K ;
SCHULZE, A ;
SPITKOVSKY, D ;
FRIEDMAN, V ;
HENGLEIN, B ;
JANSENDURR, P .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6389-6399
[44]  
ZerfassThome K, 1996, ONCOGENE, V13, P2323
[45]  
Zwerschke W, 1996, ONCOGENE, V12, P213